Summit Therapeutics Plc Stock Price on November 14, 2024
| SMMT Stock | USD 18.46 0.48 2.53% |
Below is the normalized historical share price chart for Summit Therapeutics PLC extending back to March 04, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Summit Therapeutics stands at 18.46, as last reported on the 30th of November, with the highest price reaching 19.14 and the lowest price hitting 18.40 during the day.
If you're considering investing in Summit Stock, it is important to understand the factors that can impact its price. Summit Therapeutics is relatively risky given 3 months investment horizon. Summit Therapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.0% are justified by taking the suggested risk. Use Summit Therapeutics PLC Risk Adjusted Performance of 0.0814, coefficient of variation of 1059.15, and Semi Deviation of 5.32 to evaluate company specific risk that cannot be diversified away.
At this time, Summit Therapeutics' Common Stock Shares Outstanding is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 213.1 M in 2024, whereas Common Stock is likely to drop slightly above 4.7 M in 2024. . Price To Sales Ratio is likely to drop to 1,275 in 2024. Price Earnings Ratio is likely to drop to -2.76 in 2024. Summit Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of March 2015 | 200 Day MA 11.0398 | 50 Day MA 20.4287 | Beta (0.92) |
Summit |
Sharpe Ratio = 0.1033
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SMMT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.67 actual daily | 86 86% of assets are less volatile |
Expected Return
| 1.0 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Summit Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Summit Therapeutics by adding it to a well-diversified portfolio.
Price Book 31.8946 | Enterprise Value Ebitda (5.32) | Price Sales 753.9008 | Shares Float 105.1 M | Wall Street Target Price 27.032 |
Related Headline
Inhibrx Headline on 14th of November 2024
Inhibrx Biosciences Reports Third Quarter 2024 Financial Res... by news.google.com
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results BioSpace
Summit Therapeutics Valuation on November 14, 2024
It is possible to determine the worth of Summit Therapeutics on a given historical date. On November 14, 2024 Summit was worth 19.88 at the beginning of the trading date compared to the closed value of 19.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Summit Therapeutics stock. Still, in general, we apply an absolute valuation method to find Summit Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Summit Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Summit Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 21.27 | 21.74 | 19.43 | 19.47 | 1,895,193 | |
11/14/2024 | 19.88 | 20.15 | 19.37 | 19.45 | 1,812,204 |
| 19.45 | 19.45 | 18.23 | 18.31 | 2,097,144 |
| Backtest Summit Therapeutics | | | Summit Therapeutics History | | | Summit Therapeutics Valuation | Previous | Next |
Summit Therapeutics Trading Date Momentum on November 14, 2024
| On November 15 2024 Summit Therapeutics PLC was traded for 18.31 at the closing time. The top price for the day was 19.45 and the lowest listed price was 18.23 . The trading volume for the day was 2.1 M. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 5.86% . The trading price change against the current closing price is 1.03% . |
Summit Therapeutics PLC Fundamentals Correlations and Trends
By evaluating Summit Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Summit Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Summit financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Summit Therapeutics Stock history
Summit Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Summit is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Summit Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Summit Therapeutics stock prices may prove useful in developing a viable investing in Summit Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 619.6 M | 650.6 M | |
| Net Loss | -70.9 M | -67.4 M |
Summit Therapeutics Quarterly Net Working Capital |
|
Summit Therapeutics Stock Technical Analysis
Summit Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Summit Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Summit Therapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Summit Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Summit Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Summit Therapeutics shares will generate the highest return on investment. By undertsting and applying Summit Therapeutics stock market strength indicators, traders can identify Summit Therapeutics PLC entry and exit signals to maximize returns
Summit Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Summit Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Summit Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Summit to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0814 | |||
| Jensen Alpha | 0.5187 | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | 0.1323 | |||
| Treynor Ratio | 0.3089 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.